Daly Richard J — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Daly Richard J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $474K.
Profile
Richard J. Daly is the President and CEO of Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare neuromuscular and neurological diseases. He has held various roles within the company, including Director, and has been instrumental in advancing its drug development pipeline.
Role
President and CEO, Director
Notability
50/100
Board memberships
Catalyst Pharmaceuticals, Inc.
Awards & honors
Led the development of FIRDAPSE
Expanded the company's drug portfolio
Increased company visibility in the biopharmaceutical sector
Richard J. Daly is the President and CEO of Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare neuromuscular and neurological diseases. He has held various roles within the company, including Director, and has been instrumental in advancing its drug development pipeline.…
Has Daly Richard J been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($474K) across all tracked filings.
Where can I see all of Daly Richard J's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
